Later, in the case of human breast cancer cells, the application of DHA at a concentration of 0.5–10 μm has been shown to reduce the expression of the SCN5A gene by binding to the DHA lipid-sensitive nuclear receptor, thereby reducing the latent state of Nav1.5. This evidence concerns the gene SCN5A and breast carcinoma.